4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-009904
Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PISKEL KYLE Chief Financial Officer | 2025-05-16 | Sale | −1,929 | $8.89 | $17,149 | 269,581 | D: show line 1 in the form |
| Open-market sales · 1,929 sh · avg $8.89 · $17,149 | |||||||
Loading xslF345X05/form4a.xml…